Six U-M medical research teams picked for virtual science tournament

From lab research on diabetes, aortic aneurysms and ALS to data on veteran suicide, Medicaid policy impacts and HIV in newborns, they’re competing in STAT Madness

2:00 PM

Author | Kara Gavin

Illustration of scientists and doctors playing basketball in white coats and scrubs

Updated multiple times as successive rounds began.

March means tournament time for the University of Michigan – not just for the basketball teams, but for the medical scientists too. And U-M scientific teams have just made the grade again, for the tenth year in a row.

Six teams led by U-M biomedical researchers have made the bracket of 64 teams from around the country in a national virtual tournament of science run by the STAT health news organization. Called STAT Madness, it raises awareness of major advances in medical research published in 2025, and gives the public a chance to vote for their favorite teams throughout March. 

Voting in the first round began March 2. The winners of each matchup advanced to the next round, and by early April the final two teams will face off for the prize of being featured in a STAT article. 

But the real prize for all the competitors is a chance to show the importance of research that can improve understanding of human health and the delivery of health care. It also shines a spotlight on the crucial role of the federal funding that makes most of that research possible.

Here are the six U-M studies that made the bracket this year:

Aortic aneurysms and triglycerides:

Published in the journal Circulation, and competing under the Frankel Cardiovascular Center banner, this study showed for the first time the key role of high blood triglyceride level in the formation of aortic aneurysms – and the impact of a drug candidate that lowers both triglycerides and aneurysm risk. Learn more about the pre-clinical finding here. Update: This team made it through to the championship round. Voting ends April  6 at 9 p.m. ET.

ALS blood biomarkers: 

Competing under the Michigan Medicine team banner is a team whose work published in Nature Communications shows promise for developing blood tests that could speed the diagnosis, and predict the course, of amyotrophic lateral sclerosis, also called ALS or Lou Gehrig’s disease. Read more about the findings here. Update: This team made it to the "Sweet Sixteen" round.

Mitochondria damage and diabetes: 

Competing on behalf of the Caswell Diabetes Center, a team whose work published in Science showed the crucial role of mitochondria in beta cells, which produce insulin in the pancreas – and the role of damage to mitochondria in diabetes. Read more about the discovery here. 

Medicaid interruptions and young people with chronic disease:

The first of two competitors listed under C.S. Mott Children’s Hospital, this study published in Pediatrics is especially timely because of Medicaid changes on the horizon across the country. It shows how policy changes can disrupt access to medications that children and young adults take to treat chronic diseases. Find out more here.

Missed chances to prevent HIV transmission at birth:

The second Mott Hospital entry found that some babies born to women with HIV in the United States are missing out on the chance to receive medications at birth that could reduce their risk of infection. Published in Pediatrics, it points out missed detection of HIV in pregnancy. Read more about the study here. Update: This team made it through to the second round of the tournament.

Predicting veteran suicide risk:

This study, published in JAMA Network Open by a U-M/Veterans Affairs team, used data from a nationwide VA veteran suicide prevention program to identify the factors most linked to suicide deaths, so that more effort can be made to reduce the toll. The paper is competing under the name of the Eisenberg Family Depression Center. Explore the findings, and their implications, here.

Want to support U-M scientists throughout the tournament? Sign up on the STAT Madness bracket site to get alerted when every new round of voting begins. 


More Articles About:

Basic Science and Laboratory Research Health Care Delivery, Policy and Economics Diabetes Cardiovascular: Diseases & Conditions Aortic Aneurysm ALS Soldiers and War veterans Mental Health HIV and AIDS Children's Health Medicaid

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories

Michael Powers pictured here holding a fish he caught as he stands in a boat. He struggled with pancreatitis for several decades and found answers at University of Michigan Health.
Health Lab

Patient with rare form of diabetes finds answers in genetic testing, clinical trials

Discover how genetic testing and a groundbreaking clinical trial helped one man overcome rare hyperchylomicronemia, high triglycerides, and pancreatitis.
Research image of rat blood vessels before and after norrin treatment
Health Lab

Treatment with norrin helped maintain healthy blood vessels, preserved vision in diabetic rats

Study reveals norrin treatment prevents vision loss from diabetic retinopathy in early and late stages, paving the way for new therapies.
Three people in a bar watch a television displaying a sports logo and a person smiling. Shelves with bottles and a counter with glasses are visible.
Health Lab

Jalen Hurts’ blood clot diagnosis: doctors answer common questions

After Jalen Hurts’ blood clot diagnosis, Michigan Medicine experts explain clot risks, treatment and returning safely to sports.
Woman's torso in a blue hospital gown, with her hands holding a pregnant belly and an IV in place.
Health Lab

High dose oxytocin protocol linked to lower postpartum hemorrhage rates

A change in how oxytocin is administered after childbirth may help reduce postpartum hemorrhage, a new study suggests.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
Perforin increases endosomal-mitochondrial contact sites in tumor cells. Left is without perforin; right has perforin.
Health Lab

Immune system protein is a cancer killer on its own, new study shows

New study finds perforin can kill cancer tumor cells even when major granzymes were missing.